19-41878987-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001783.4(CD79A):c.80-3C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000708 in 1,412,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001783.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD79A | NM_001783.4 | c.80-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000221972.8 | NP_001774.1 | |||
CD79A | NM_021601.4 | c.80-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_067612.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD79A | ENST00000221972.8 | c.80-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001783.4 | ENSP00000221972 | P1 | |||
CD79A | ENST00000444740.2 | c.80-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000400605 | |||||
CD79A | ENST00000597454.2 | c.80-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 3 | ENSP00000468922 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246188Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134090
GnomAD4 exome AF: 7.08e-7 AC: 1AN: 1412820Hom.: 0 Cov.: 30 AF XY: 0.00000142 AC XY: 1AN XY: 703714
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Agammaglobulinemia 3, autosomal recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 02, 2020 | This variant has not been reported in the literature in individuals with CD79A-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing, but this prediction has not been confirmed by published transcriptional studies. This variant is present in population databases (rs781874528, ExAC 0.002%). This sequence change falls in intron 1 of the CD79A gene. It does not directly change the encoded amino acid sequence of the CD79A protein, but it affects a nucleotide within the consensus splice site of the intron. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at